Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / India News / Serum Institute gets notice after AstraZeneca halts coronavirus vaccine trial
    Next Article
    Serum Institute gets notice after AstraZeneca halts coronavirus vaccine trial

    Serum Institute gets notice after AstraZeneca halts coronavirus vaccine trial

    By Shalini Ojha
    Sep 11, 2020
    12:54 am

    What's the story

    Drug Controller General of India (DCGI) sent a notice to the Serum Institute of India (SII) asking why trials for the coronavirus vaccine candidate, developed by the University of Oxford, were not halted even when UK-based pharma giant AstraZeneca had stopped the process after a volunteer fell ill.

    SII responded that it will abide by directions but it hasn't been asked to stop trials, just yet.

    Background

    Context: After volunteer had a reaction, late-stage trial was paused

    In an unwelcome development, AstraZeneca disclosed on Tuesday that it was pausing late-stage trial after a UK-based volunteer had an "adverse reaction."

    The company said such incidents aren't entirely uncommon in large-scale trials while adding that it was taking steps to mitigate the impact on the vaccine timeline.

    The vaccine, termed as a frontrunner in the global race, was found to be effective earlier.

    You're
    16%
    through

    Details

    Volunteer who fell ill was a woman, had neurological symptoms

    While initially, extensive details about the illness weren't revealed, AstraZeneca's CEO Pascal Soriot told investors that the volunteer who took ill was a woman.

    She had "neurological symptoms consistent with a rare but serious spinal inflammatory disorder called transverse myelitis," StatNews reported.

    Soriot also said that though the diagnosis hasn't been confirmed, the woman was recovering and could be discharged soon.

    You're
    33%
    through

    India's impact

    Despite global halt, SII continued the process

    After the illness was reported, AstraZeneca stopped trials globally, but its India partner SII decided against it.

    On Wednesday, the Pune-based firm said it will not change the process and declared that it hasn't faced any issues. SII also said it "can't comment on the UK trials," adding that the trials were "paused for further review."

    By evening, SII had gotten a notice.

    You're
    50%
    through

    Notice

    Why didn't you inform about trials being paused, asked DCGI

    In the show-cause notice, Director Dr. VG Somani asked SII why permission to conduct trials in India shall not be suspended until the UK candidate's safety is determined.

    According to PTI, DCGI was also critical of the fact that SII didn't inform about global trials being paused.

    DCGI said SII didn't submit "casualty analysis of the reported serious adverse event" either.

    You're
    66%
    through

    Quote

    SII was asked to explain why permission shouldn't be suspended

    "[We] give you an opportunity to show cause as provided under rule 30 of the New Drugs and Clinical Trials Rules, 2019, why the permission granted to you August 2 shall not be suspended till patient safety is established, (sic)" the notice added.

    You're
    83%
    through

    Response

    Will follow instructions, said SII after notice

    After the notice gained public attention, SII said it was willing to abide by all guidelines.

    "If DCGI (Drug Controller General of India) has any safety concerns, we will follow their instructions and abide by the standard protocols," the world's largest vaccine manufacturer told ET.

    Notably, SII started trials in India last month and plans to conduct tests across 17 sites.

    Done!
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    University of Oxford
    Coronavirus
    Serum Institute of India
    AstraZeneca

    Latest

    'Sirens,' 'Nine Perfect Strangers': Your OTT watchlist this week Nicole Kidman
    'Fear Street: Prom Queen': Cast, plot, release details OTT releases
    IPL 2025, LSG vs SRH: How the Impact Players fared  Sunrisers Hyderabad (SRH)
    Microsoft employee disrupts Nadella's keynote: What's behind the protest? Satya Nadella

    University of Oxford

    Groceries at your doorstep, delivered by self-driving cars Startups
    Indian-origin scientist Pratibha Gai awarded Britain's royal damehood India
    Indian 'Forbes 30 Under 30' to speak at LSE Forum India
    Oxford University crash course for two Indian teaching Olympiad winners Mumbai

    Coronavirus

    PM-CARES to fund two coronavirus hospitals in Bihar, opposition unhappy Bihar
    Legendary sprinter Usain Bolt tests positive for coronavirus Chris Gayle
    HK man gets reinfected by coronavirus: What does it mean Vaccine
    Korea: 'Tenet' fares well, but coronavirus forces theaters to close South Korea

    Serum Institute of India

    Amid coronavirus crisis, this Indian business tycoon is growing richer Mukesh Ambani
    India will start COVID-19 vaccine production next month: Details here Oxford
    COVID-19 vaccine: What are the latest updates? AstraZeneca
    COVID-19 vaccine: What are the latest updates? COVID-19

    AstraZeneca

    #GoodNews: Oxford's COVID-19 vaccine may be available by September-end Oxford
    As coronavirus pandemic surges, some vaccine makers expect to profit Pfizer
    Meet Adar Poonawalla, the man bringing COVID-19 vaccines to India Oxford University
    Coronavirus: How much would the vaccines cost? Coronavirus
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025